Preoperative Maximum Inspiratory Pressure and Outcomes After Interscalene Block in Obese Patients

NCT ID: NCT06549244

Last Updated: 2024-08-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

45 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-07-01

Study Completion Date

2024-01-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study aims to explore if Maximum Inspiratory Pressure can predict postoperative breathlessness in obese patients receiving interscalene blocks for shoulder surgery.

The main question is: does baseline Maximum Inspiratory Pressure have any association with postoperative breathlessness after interscalene blocks in class 2 or higher obese patients (BMI\>35).

Preoperative and postoperative lung volumes, pressures, breathlessness score and respiratory outcomes will be measured on participants already receiving shoulder surgery with interscalene blocks.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dyspnea After Interscalene Nerve Block

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Block, Non-obese

Non-obese, Body Mass Index (BMI)\<30, receiving interscalene block and general anesthesia for shoulder surgery

Maximum Inspiratory Pressure monitoring

Intervention Type DIAGNOSTIC_TEST

Lung volumes, pressures and breathlessness scores to be measured in pre and post operative phase of care on the same day

Block, Obese

Class 2 or higher Obese, BMI\>35, receiving interscalene block and general anesthesia for shoulder surgery

Maximum Inspiratory Pressure monitoring

Intervention Type DIAGNOSTIC_TEST

Lung volumes, pressures and breathlessness scores to be measured in pre and post operative phase of care on the same day

Control

control group, included non-shoulder surgery patients receiving general anesthesia only

Maximum Inspiratory Pressure monitoring

Intervention Type DIAGNOSTIC_TEST

Lung volumes, pressures and breathlessness scores to be measured in pre and post operative phase of care on the same day

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Maximum Inspiratory Pressure monitoring

Lung volumes, pressures and breathlessness scores to be measured in pre and post operative phase of care on the same day

Intervention Type DIAGNOSTIC_TEST

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Spirometry measurements, Modified Borg breathlessness questionnaire

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults \>18 years of age receiving shoulder surgery with preoperative interscalene block and general anesthesia;
* Speak English;

Group 3

ยท Adults \>18 years of age receiving cystoscopy or lower extremity procedures receiving general endotracheal anesthesia

Exclusion Criteria

* Less than 18 years of age;
* currently pregnant;
* currently incarcerated;
* those with significant neuromuscular disease, tracheo-bronchial structural abnormalities, severe respiratory or severe cardiovascular comorbidity;
* those undergoing intra-abdominal or intrathoracic surgeries due to the potential to independently effect breathing
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of North Carolina, Chapel Hill

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Monika Nanda

Role: PRINCIPAL_INVESTIGATOR

University of North Carolina

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of North Carolina

Chapel Hill, North Carolina, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

23-0924

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.